VTVT vTv Therapeutics Inc

Price (delayed)

$34.71

Market cap

$136.72M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.46

Enterprise value

$38.63M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 51

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by programs for the treatment ...

Highlights
The net income has surged by 112% year-on-year and by 108% since the previous quarter
VTVT's debt has dropped by 100% year-on-year

Key stats

What are the main financial stats of VTVT

VTVT stock price

How has the vTv Therapeutics stock price performed over time
Intraday
5.37%
1 week
3.61%
1 month
6.8%
1 year
116.94%
YTD
-13.2%
QTD
-12.48%

Financial performance

How have vTv Therapeutics's revenue and profit performed over time
Revenue
$36.84M
Gross profit
$36.84M
Operating income
-$2.96M
Net income
$2.25M
Gross margin
100%
Net margin
6.1%
The net income has surged by 112% year-on-year and by 108% since the previous quarter
VTVT's net margin has surged by 100% year-on-year
The operating margin has soared by 100% YoY
VTVT's operating income has soared by 91% QoQ and by 88% YoY

Price vs fundamentals

How does VTVT's price correlate with its fundamentals

Growth

What is vTv Therapeutics's growth rate over time

Valuation

What is vTv Therapeutics stock price valuation
P/E
N/A
P/B
1.52
P/S
11.69
EV/EBIT
17.11
EV/EBITDA
17.05
EV/Sales
1.05
The company's EPS has surged by 86% QoQ and by 84% YoY
VTVT's price to book (P/B) is 74% lower than its last 4 quarters average of 5.6
VTVT's equity is up by 40% since the previous quarter
The P/S is 99% lower than the 5-year quarterly average of 1841.6

Efficiency

How efficient is vTv Therapeutics business performance
vTv Therapeutics's return on assets has surged by 107% QoQ and by 106% YoY
vTv Therapeutics's return on equity has surged by 105% QoQ and by 103% YoY
The company's return on sales has surged by 100% YoY

Dividends

What is VTVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VTVT.

Financial health

How did vTv Therapeutics financials performed over time
The quick ratio has soared by 98% YoY and by 6% from the previous quarter
The current ratio has soared by 94% year-on-year and by 6% since the previous quarter
VTVT's debt is 100% smaller than its equity
The debt to equity has dropped by 100% year-on-year
VTVT's debt has dropped by 100% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.